Top

CardioVascular and Interventional Radiology

Published in:

01-10-2016 | Clinical Investigation

Percutaneous Transluminal Angioplasty for Complete Membranous Obstruction of Suprahepatic Inferior Vena Cava: Long-Term Results

Authors: Fahrettin Kucukay, Meral Akdogan, Erdal Birol Bostanci, Ahmet Tulga Ulus, Murat Bulent Kucukay

Published in: CardioVascular and Interventional Radiology | Issue 10/2016

Abstract

Purpose

To determine the long-term results of percutaneous transluminal angioplasty (PTA) for a complete membranous obstruction of the suprahepatic inferior vena cava.

Methods

Patients (n = 65) who were referred to the interventional unit for PTA for a complete membranous obstruction of the suprahepatic inferior vena cava between January 2006 and October 2014 were included in the study. Thirty-two patients (18 males, 14 females, mean age 35 ± 10.7, range 20–42 years) were treated. The patients presented with symptoms of ascites (88 %), pleural effusion (53 %), varicose veins (94 %), hepatomegaly (97 %), abdominal pain (84 %), and splenomegaly (40 %). Transjugular liver access set and re-entry catheter were used to puncture and traverse the obstruction from the jugular side. PTA balloon dilations were performed. The mean follow-up period was 65.6 ± 24.5 months. The objective was to evaluate technical success, complications, primary patency, and clinical improvement in the symptoms of the patients.

Results

The technical success rate was 94 %. In two patients, obstruction could not be traversed. These patients underwent cavoatrial graft bypass surgery. There were no procedure-related complications. Clinical improvements were achieved in all patients within 3 months. The primary patency rate at 4 years was 90 %. There was no primary assisted patency. There was no need for metallic stent deployment in the cohort. The secondary patency rate at 4 years was 100 %.

Conclusions

Percutaneous transluminal angioplasty for a complete membranous obstruction of the suprahepatic inferior vena cava is safe and effective, and the long-term results are excellent.

DeLeve LD, Valla DC, Garcia-Tsao G, American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49(5):1729–64.PubMedCrossRef

Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC, European Group for the Study of Vascular Disorders of the Liver. Budd–Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38(3):364–71.PubMedCrossRef

Shrestha SM. Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava). World J Hepatol. 2015;7(6):874–84.PubMedPubMedCentralCrossRef

Copelan A, Remer EM, Sands M, Nghiem H, Kapoor B. Diagnosis and management of Budd Chiari syndrome: an update. Cardiovasc Intervent Radiol. 2015;38(1):1–12.PubMedCrossRef

Cura M, Haskal Z, Lopera J. Diagnostic and interventional radiology for Budd–Chiari syndrome. Radiographics. 2009;29(3):669–81.PubMedCrossRef

Ciesek S, Rifai K, Bahr MJ, Boozari B, Steinmann E, Helfritz FA, Wedemeyer H, Manns MP, Lotz J, Gebel M. Membranous Budd–Chiari syndrome in Caucasians. Scand J Gastroenterol. 2010;45(2):226–34.PubMedCrossRef

Zhang F, Wang C, Li Y. The outcomes of interventional treatment for Budd–Chiari syndrome: systematic review and meta-analysis. Abdom Imaging. 2015;40(3):601–8.PubMedCrossRef

Yang XL, Cheng TO, Chen CR. Successful treatment by percutaneous balloon angioplasty of Budd–Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. J Am Coll Cardiol. 1996;28(7):1720–4.PubMedCrossRef

Zhang Q, Huang Q, Shen B, Sun J, Wang X, Liu H. Efficacy and safety of endovascular intervention for the management of primary entire-inferior vena cava occlusion. Cardiovasc Intervent Radiol. 2015;38(3):665–71.PubMedCrossRef

10.

Lee BB, Villavicencio L, Kim YW, Do YS, Koh KC, Lim HK, Lim JH, Ahn KW. Primary Budd–Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. J Vasc Surg. 2006;43(1):101–8.PubMedCrossRef

11.

Ding PX, Zhang SJ, Li Z, Fu MT, Hua ZH, Zhang WG. Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd–Chiari syndrome. J Gastroenterol Hepatol. 2016;31(1):222–8.PubMedCrossRef

12.

Park JH, Chung JW, Han JK, Han MC. Interventional management of benign obstruction of the hepatic inferior vena cava. J Vasc Interv Radiol. 1994;5(3):403–9.PubMedCrossRef

13.

Srinivas BC, Dattatreya PV, Srinivasa KH, Manjunath CN. Inferior vena cava obstruction: long-term results of endovascular management. Indian Heart J. 2012;64(2):162–9.PubMedPubMedCentralCrossRef

14.

Kandpal H, Sharma R, Gamangatti S, Srivastava DN, Vashisht S. Imaging the inferior vena cava: a road less traveled. Radiographics. 2008;28(3):669–89.PubMedCrossRef

15.

Haskal ZJ, Dumbleton SA, Holt D. Percutaneous treatment of caval obstruction and Budd–Chiari syndrome in a cat. J Vasc Interv Radiol. 1999;10(4):487–9.PubMedCrossRef

16.

Fine DM, Olivier NB, Walshaw R, Schall WD. Surgical correction of late-onset Budd–Chiari-like syndrome in a dog. J Am Vet Med Assoc. 1998;212(6):835–7.PubMed

17.

Simson IW. Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology. 1982;82(2):171–8.PubMed

18.

Okuda K. Membranous obstruction of the inferior vena cava: etiology and relation to hepatocellular carcinoma. Gastroenterology. 1982;82(2):376–9.PubMed

19.

Kew MC, Hodkinson HJ. Membranous obstruction of the inferior vena cava and its causal relation to hepatocellular carcinoma. Liver Int. 2006;26(1):1–7.PubMedCrossRef

20.

Rector WG Jr, Xu YH, Goldstein L, Peters RL, Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine. 1985;64(2):134–43.PubMedCrossRef

Title: Percutaneous Transluminal Angioplasty for Complete Membranous Obstruction of Suprahepatic Inferior Vena Cava: Long-Term Results
Authors: Fahrettin Kucukay
Meral Akdogan
Erdal Birol Bostanci
Ahmet Tulga Ulus
Murat Bulent Kucukay
Publication date: 01-10-2016
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 10/2016
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-016-1394-2

2024 ASCO Annual Meeting

Springer Medicine

Percutaneous Transluminal Angioplasty for Complete Membranous Obstruction of Suprahepatic Inferior Vena Cava: Long-Term Results

Abstract

Purpose

Methods

Results

Conclusions

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2016

Curved Needles in CT-Guided Fine Needle Biopsies of Pulmonary Lesions: an Ability to Reduce the Incidence of Pneumothorax

Transcatheter Arterial Embolization for Life-Long Urinary Incontinence Associated with Bilateral Ureteral Duplication with Ectopia

Percutaneous Image-Guided Screw Fixation of Bone Lesions in Cancer Patients: Double-Centre Analysis of Outcomes including Local Evolution of the Treated Focus

Technical and Clinical Outcomes Following Colonic Stenting: A Seven-Year Analysis of 268 Procedures

Successful Management of Neobladder Variceal Bleeding

Percutaneous Biopsy and Radiofrequency Ablation of Osteoid Osteoma with Excess Reactive New Bone Formation and Cortical Thickening Using a Battery-Powered Drill for Access: A Technical Note